
Sign up to save your podcasts
Or


Could Swiss pharmaceutical company Roche’s late-stage antibiotic trials signal new hope against antibiotic‐resistant pathogens? On this special REPLAY episode (originally aired August 2024), we take a deep dive into the state of antimicrobial resistance, from hospital wards to farm fields. As these microscopic threats drive up healthcare costs, jeopardize food security, and reshape insurance risk worldwide, understanding the crisis has never been more critical. But while the need to act is clear, the solutions remain complex. In this episode, we examine whether there’s a compelling investment case for fighting back, and what that could mean for the future of global health.
Host: Bentley Kaplan
Guest: Namita Nair
By MSCI ESG Research LLC4.8
134134 ratings
Could Swiss pharmaceutical company Roche’s late-stage antibiotic trials signal new hope against antibiotic‐resistant pathogens? On this special REPLAY episode (originally aired August 2024), we take a deep dive into the state of antimicrobial resistance, from hospital wards to farm fields. As these microscopic threats drive up healthcare costs, jeopardize food security, and reshape insurance risk worldwide, understanding the crisis has never been more critical. But while the need to act is clear, the solutions remain complex. In this episode, we examine whether there’s a compelling investment case for fighting back, and what that could mean for the future of global health.
Host: Bentley Kaplan
Guest: Namita Nair

977 Listeners

296 Listeners

1,252 Listeners

399 Listeners

506 Listeners

684 Listeners

132 Listeners

232 Listeners

466 Listeners

103 Listeners

61 Listeners

80 Listeners

178 Listeners

279 Listeners

230 Listeners